| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |